FDA completes re-inspection of Akorn Decatur facility
LAKE FOREST - The U.S. Food and Drug Administration recently conducted a re-inspection of Akorn Inc.'s manufacturing facility in Decatur.
The re-inspection was conducted to verify the implementation and effectiveness of the specialty pharmaceutical company's responses to the observations from the June 2016 FDA inspection.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.